These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 470792

  • 21. [Amikacin, in association, in severe infections due to Gram-negative bacteria].
    Dureux JB, Canton Ph, Etienne Y, Neiman L.
    Nouv Presse Med; 1979 Oct 31; 8(42):3492-5. PubMed ID: 537902
    [No Abstract] [Full Text] [Related]

  • 22. Treatment of hospita-acquired infections with amikacin.
    Doughty SC, Martin RR, Greenberg SB.
    Am J Med; 1977 Jun 31; 62(6):889-93. PubMed ID: 868903
    [Abstract] [Full Text] [Related]

  • 23. [Comparative clinical effect of amikacin and gentamicin on complicated urinary tract infections by doubld-blind method (author's transl)].
    Nishiura T, Kawada Y, Ichikawa T, Nakano I, Tsuji I, Kumamoto Y, Shishido S.
    Nihon Hinyokika Gakkai Zasshi; 1978 Mar 31; 69(3):381-98. PubMed ID: 351248
    [No Abstract] [Full Text] [Related]

  • 24. Ototoxicity and pharmacokinetically determined dosages of amikacin in granulocytopenic cancer patients.
    Danhauer FJ, Fortner CL, Schimpff SC, deJongh CA, Wesley MN, Wiernik PH.
    Clin Pharm; 1982 Mar 31; 1(6):539-43. PubMed ID: 7185540
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Enzymuria in aminoglycoside-induced kidney damage. Comparative study of gentamicin, amikacin, sisomicin and netilmicin.
    Palla R, Marchitiello M, Tuoni M, Cirami C, Giovannini L, Bertelli AA, Bertelli A.
    Int J Clin Pharmacol Res; 1985 Mar 31; 5(5):351-5. PubMed ID: 2866167
    [Abstract] [Full Text] [Related]

  • 27. [Clinical efficacy, nephrotoxicity and ototoxicity of amikacin].
    Federspil P, Schindler K, Weich C, Tiesler E, Schätzle W, Ziegler M.
    Infection; 1979 Mar 31; 7(2):81-7. PubMed ID: 374277
    [Abstract] [Full Text] [Related]

  • 28. Amikacin therapy of patients with multiply antibiotic-resistant Serratia marcescens infections: development of increasing resistance during therapy.
    Craven PC, Jorgensen JH, Kaspar RL, Drutz DJ.
    Am J Med; 1977 Jun 31; 62(6):902-10. PubMed ID: 326046
    [Abstract] [Full Text] [Related]

  • 29. A review of results of clinical trials with amikacin.
    Gooding PG, Berman E, Lane AZ, Agre K.
    J Infect Dis; 1976 Nov 31; 134 SUPPL():S441-5. PubMed ID: 792360
    [Abstract] [Full Text] [Related]

  • 30. [Treatment of highly resistant germs by dibekacin in patients with urinary tract infections (author's transl)].
    Peters HJ.
    Med Klin; 1979 Jul 06; 74(27):1063-6. PubMed ID: 470791
    [Abstract] [Full Text] [Related]

  • 31. Amikacin Therapy of Urinary tract infections.
    Cox CE.
    J Infect Dis; 1976 Nov 06; 134 SUPPL():S362-8. PubMed ID: 792358
    [Abstract] [Full Text] [Related]

  • 32. Frequency and susceptibility profile of pathogens causing urinary tract infections at a tertiary care hospital in western Nepal.
    Das RN, Chandrashekhar TS, Joshi HS, Gurung M, Shrestha N, Shivananda PG.
    Singapore Med J; 2006 Apr 06; 47(4):281-5. PubMed ID: 16572238
    [Abstract] [Full Text] [Related]

  • 33. Amikacin in treatment of infections caused by gram-negative bacteria resistant to gentamicin and other aminoglycosides: clinical and bacteriologic results.
    Daikos GK, Kosmidis JC, Hamilton-Miller JM, Brumfitt W.
    J Infect Dis; 1976 Nov 06; 134 SUPPL():S286-90. PubMed ID: 993623
    [Abstract] [Full Text] [Related]

  • 34. A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.
    De Jongh CA, Joshi JH, Thompson BW, Newman KA, Finley RS, Moody MR, Salvatore PC, Tenney JH, Drusano GL, Schimpff SC.
    Am J Med; 1986 May 30; 80(5C):101-11. PubMed ID: 3521269
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Amikacin therapy for gram-negative septicemia.
    Meyer RD, Lewis RP, Finegold SM.
    Am J Med; 1977 Jun 30; 62(6):930-5. PubMed ID: 868908
    [Abstract] [Full Text] [Related]

  • 37. [Pharmacokinetics and clinical experiences with a new aminoglycoside antibioticum: amikacin].
    Lode H, Grunert K, Koeppe P, Langmaack H.
    Verh Dtsch Ges Inn Med; 1976 Jun 30; 82 Pt 2():1684-6. PubMed ID: 1030080
    [No Abstract] [Full Text] [Related]

  • 38. Clinical evaluation of amikacin in treatment of infections due to gram-negative aerobic bacilli.
    Mathias RG, Ronald AR, Gurwith MJ, McCullough DW, Stiver HG, Berger J, Cates CY, Fox LM, Lank BA.
    J Infect Dis; 1976 Nov 30; 134 SUPPL():S394-401. PubMed ID: 825590
    [Abstract] [Full Text] [Related]

  • 39. Isepamicin versus amikacin in the treatment of urinary tract infection.
    Sturm W.
    J Chemother; 1995 Jun 30; 7 Suppl 2():149-54. PubMed ID: 8622104
    [Abstract] [Full Text] [Related]

  • 40. [Amikacin therapy for serious infections in hematopoietic disorders (author's transl)].
    Fujii H, Shimizu T.
    Jpn J Antibiot; 1981 Jun 30; 34(6):841-51. PubMed ID: 7289039
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.